Health & Biotech
ASX Health Stocks: HitIQ soars 40pc after signing footy deal; Rhythm Bio expands to NZ
Health & Biotech
Check Up: These 4 ASX healthcare stocks come with Strong Buy recommendations
Health & Biotech
Wholesome margins await as Wellnex e-platform, brand launch muscles into untapped online riches
Health & Biotech
ASX Biotech Stocks: HitIQ nabs landmark deal with Premier League for its concussion management tech
Health & Biotech
Nanollose teams with Paradise Textiles to produce fabric using its Forest-Friendly Nullarbor fibre
Health & Biotech
ASX Biotech Stocks: Surgeons can now be reimbursed for using Orthocell’s nerve repair device
Health & Biotech
Creso welcomes news that US cannabis banking and expungements bill is close
Health & Biotech
ASX Biotech Stocks: Nuheara secures historic FDA clearance for its over-the-counter hearing aid
Health & Biotech
Osteopore hits record revenue in Q3 and achieves 4 consecutive quarters of revenue growth, ticks boxes for future growth
Health & Biotech
Successful navigation of a ‘difficult period’: Equity firm ups its 12-month target price for EZZ
Health & Biotech
ScoPo’s Powerplays: Is it time to fill the Christmas stocking early with some ASX health stocks?
Health & Biotech
ASX Biotech Stocks: Clover can boost premature kids IQs, First Graphene nabs US patent for supercapacitor tech
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.